126 related articles for article (PubMed ID: 4099204)
21. Thyroid suppressibility and long-acting thyroid stimulator in thyrotoxicosis.
Silverstein GE; Burke G
Arch Intern Med; 1970 Oct; 126(4):615-20. PubMed ID: 4097002
[No Abstract] [Full Text] [Related]
22. The nucleic acid content of lymphocytes in thyrotoxicosis.
Smith JF; Glen AC; Greig WR
Clin Exp Immunol; 1971 Jun; 8(6):911-6. PubMed ID: 5104635
[TBL] [Abstract][Full Text] [Related]
23. [Effect of iodine administration on the thyrotropic hormone and long-acting thyroid stimulator level in the plasma].
Földes J; Krasznai I; Piroska E; Gesztesi E; Takács I
Endokrinologie; 1967; 52(1):80-7. PubMed ID: 4171706
[No Abstract] [Full Text] [Related]
24. Neonatal thyrotoxicosis.
Hopton DS; Wade JS
Proc R Soc Med; 1969 Aug; 62(8):817. PubMed ID: 4185737
[No Abstract] [Full Text] [Related]
25. The bioassay of long-acting thyroid stimulator: a comparison of two methods.
Ensor JM; Kendall-Taylor P; Munro DS; Smith BR
J Endocrinol; 1971 Mar; 49(3):487-92. PubMed ID: 5090899
[No Abstract] [Full Text] [Related]
26. The triiodothyronine suppression test in hyperthyroid patients on antithyroid medication.
Friis T
Acta Med Scand; 1965 Nov; 178(5):667-79. PubMed ID: 4158793
[No Abstract] [Full Text] [Related]
27. Hypothyroidism after treatment with sodium iodide I-131. Incidence and relationship to antithyroid antibodies, long-acting thyroid stimulator (LATS), and infiltrative ophthalmopathy.
Burke G; Silverstein GE
JAMA; 1969 Nov; 210(6):1051-8. PubMed ID: 4900342
[No Abstract] [Full Text] [Related]
28. Plasma glycerol and glycerol turnover during treatment of hyperthyroidism.
Tibbling G; Cederquist E; Lundquist A
Clin Chim Acta; 1969 Aug; 25(2):189-98. PubMed ID: 4184576
[No Abstract] [Full Text] [Related]
29. Rational management of thyroid auto-immune disease.
Adams DD
N Z Med J; 1974 Dec; 80(529):486-9. PubMed ID: 4141486
[No Abstract] [Full Text] [Related]
30. [Hyperthyroidism. Physiopathologic aspects].
Kessler FJ
Schweiz Rundsch Med Prax; 1971 May; 60(21):667-73. PubMed ID: 4103586
[No Abstract] [Full Text] [Related]
31. [The effect of thyroid antagonists and I-131 isotope therapy on the autoimmune processes in hyperthyroidism].
Takó J; Bános C
Orv Hetil; 1971 Feb; 112(9):489-91. PubMed ID: 4101139
[No Abstract] [Full Text] [Related]
32. Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies.
Pinchera A; Liberti P; Martino E; Fenzi GF; Grasso L; Rovis L; Baschieri L; Doria G
J Clin Endocrinol Metab; 1969 Feb; 29(2):231-8. PubMed ID: 4179303
[No Abstract] [Full Text] [Related]
33. CLINICAL STUDIES ON THE LONG-ACTING THYROID STIMULATOR.
NOGUCHI A; KURIHARA H; SATO S
J Clin Endocrinol Metab; 1964 Feb; 24():160-5. PubMed ID: 14123839
[No Abstract] [Full Text] [Related]
34. [The inhibition test of thyroid function with triiodothyronine in hyperthyroid patients under medical therapy: comparison of the values obtained from measures of "early" uptake and in the organic phase].
Valentini F; Reschini E; Lodeserto A; Vivarelli S; Miedico D
Folia Endocrinol; 1968 Aug; 21(4):396-403. PubMed ID: 4185869
[No Abstract] [Full Text] [Related]
35. The value of IgG separation for the detection of LATS in human serum.
Bonnyns M; Vanhaelst L
Clin Exp Immunol; 1969 May; 4(5):597-601. PubMed ID: 5815122
[TBL] [Abstract][Full Text] [Related]
36. Comparison between radioiodine and antithyroid therapy in the management of hyperthyroidism.
Cassano C; Baschieri I; Cramarossa L
Panminerva Med; 1965 Oct; 7(10):367-9. PubMed ID: 4158565
[No Abstract] [Full Text] [Related]
37. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases].
Depisch D; Höfer R; Schatz H
Wien Z Inn Med; 1968; 49(4):121-30. PubMed ID: 5757238
[No Abstract] [Full Text] [Related]
38. THYROTOXICOSIS.
THOMAS ID; HALES IB; REEVE TS
Aust N Z J Surg; 1964 May; 33():310-8. PubMed ID: 14159285
[No Abstract] [Full Text] [Related]
39. Clinical significance of LATS and TSH in the blood.
Lemarchand-Béraud T; Griessen M; Scazziga BR
Ann Clin Res; 1972 Jun; 4(3):121-37. PubMed ID: 4625026
[No Abstract] [Full Text] [Related]
40. Thyroidal suppressibility after stopping long-term treatment of thyrotoxicosis with anti-thyroid drugs.
Alexander WD; Harden RM; McLarty D; Shimmins J
Metabolism; 1969 Jan; 18(1):58-62. PubMed ID: 4179400
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
